Description: Syncona Ltd, formerly BACIT Limited, is a closed-ended investment company. The Company is engaged in investing in hedge, equity and long-term alternative investment funds across multiple asset classes. The Company's investment objective is to deliver returns from investments in long-only and alternative investment funds across multiple asset classes. The Company intends to achieve the investment objective through investments in long-only funds, hedge funds, private equity funds and real estate funds. The Company makes its investments through BACIT Investments LP Incorporated (the Partnership). The general partner of the Partnership is BACIT GP Limited (the General Partner), a subsidiary of the Company. It also invests in BACIT Discovery Limited, a subsidiary of the Partnership. The Company has also invested in the Pioneer Fund as if it were an indirect cost recovery (ICR) Project. BACIT (UK) Limited is the investment manager of the Company.
Home Page: www.synconaltd.com
SYNC Technical Analysis
215 Euston Road
London,
NW12BE
United Kingdom
Phone:
44 20 3981 7909
Officers
Name | Title |
---|---|
Mr. Thomas Henderson | Co-Founder & Non-Exec. Director |
Dr. Martin Patrick Murphy Ph.D. | Chief Exec. Officer |
Mr. John McDonald | Co-Founder |
Mr. Rolf Kristian Berndtson Soderstrom ACA, BA | Chief Financial Officer |
Dr. Christopher J. Hollowood Ph.D. | CIO & Managing Partner of Syncona Investment Management Ltd. |
Ms. Annabel Clay | Head of Investor Relations |
Mr. Andrew Cossar | Gen. Counsel of Syncona Investment Management Ltd. |
Ms. Fenella Dernie | Exec. Officer |
Mr. Edward Eliot Hodgkin DPhil | Sr. Partner |
Ms. Nikki Padden Ph.D. | Head of Fin. at Syncona Investment Management Ltd. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
Forward PE: | 0 |
---|---|
Trailing PE: | 5.4313 |
Price-to-Book MRQ: | 0.8879 |
Price-to-Sales TTM: | 5.4083 |
IPO Date: | |
Fiscal Year End: | March |
Full Time Employees: | 1180 |